SCHEMBL10073866

SCHEMBL10073866

COc1ccc2c(C(=O)c3ccc(C)nc3)nn(CC(=O)C(C)(C)C)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 1/20 0.43
DYRK1A Q13627 2/20 0.36
ABL1 P00519 1/20 0.36
BCR P11274 1/20 0.36
SPR P35270 1/20 0.35
ABCB1 P08183 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RXFP1 Q9HBX9 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ELANE P08246 2/20 0.34
PDE10A Q9Y233 1/20 0.34
MGAM O43451 1/20 0.34
AMY1A P0DUB6 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
MAPT P10636 1/20 0.34
PLA2G2A P14555 1/20 0.34
HTR3A P46098 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13794680 0.90 SSTR5 (0.43) SSTR5DYRK1ASPRABCB1ALDH1A1
SCHEMBL10074047 0.89 SSTR5 (0.42) SSTR5DYRK1ASPRABCB1ALDH1A1
SCHEMBL3913134 0.89 SSTR5 (0.42) SSTR5DYRK1ASPRABCB1ALDH1A1
SCHEMBL10074859 0.88 SSTR5 (0.41) SSTR5DYRK1ASPRABCB1ALDH1A1
SCHEMBL5001501 0.87 SSTR5 (0.41) SSTR5DYRK1ASPRABCB1ALDH1A1
SCHEMBL14094058 0.87 SSTR5 (0.41) SSTR5DYRK1ASPRABCB1ALDH1A1
SCHEMBL10074048 0.86 SSTR5 (0.40) SSTR5DYRK1AALDH1A1RXFP1ELANE
SCHEMBL3906879 0.86 SSTR5 (0.40) SSTR5DYRK1AALDH1A1RXFP1ELANE
SCHEMBL10074637 0.86 SSTR5 (0.40) SSTR5ALDH1A1MAPTHTR3A
SCHEMBL13901109 0.85 SSTR5 (0.40) SSTR5DYRK1ASPRALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562909-B1 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK SHARP & DOHME (US) 2012-06-27 EP disclosed
US-7547720-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2009-06-16 US disclosed
US-7547720-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2009-06-16 US disclosed
EP-1663987-B1 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-03-18 EP disclosed
US-7410992-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2008-08-12 US disclosed
US-7410992-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2008-08-12 US disclosed
US-20070129418-A1 Ophthalmic compositions for treating ocular hypertension MERCK SHARP & DOHME LLC 2007-06-07 US disclosed
US-20070129418-A1 Ophthalmic compositions for treating ocular hypertension MERCK SHARP & DOHME LLC 2007-06-07 US disclosed
US-7196082-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2007-03-27 US disclosed
US-7196082-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2007-03-27 US disclosed
US-20070010491-A1 Ophthalmic compositions for treating ocular hypertension MERCK SHARP & DOHME LLC 2007-01-11 US disclosed
US-20070010491-A1 Ophthalmic compositions for treating ocular hypertension MERCK SHARP & DOHME LLC 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010491-A1 Ophthalmic compositions for treating ocular hypertension REN, KCNH2, KCNH3 SSTR5 296/4885DYRK1A 4099/4885ABL1 3820/4885
US-20070129418-A1 Ophthalmic compositions for treating ocular hypertension KCNH2, KCNJ11, KCNN1 SSTR5 1031/4885DYRK1A 4545/4885ABL1 3889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.